Finch Therapeutics: Funding, Investors & Team (Sep 2026)
Finch Therapeutics is a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs. The company uses machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus on in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models. Finch Therapeutics was founded in 2017 and is headquartered in Somerville, Massachusetts.
Finch Therapeutics has raised $90.0M across 1 funding round on record, the most recent an undisclosed round of $90.0M announced in Sep 2020.
That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Finch Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2020.
Finch Therapeutics Funding Rounds
Finch Therapeutics Founders and Leadership Team
Contact details for the Finch Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Finch Therapeutics Funding Compared to Other Artificial Intelligence Startups
Finch Therapeutics' latest round of $90.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Finch Therapeutics in Artificial Intelligence and Somerville
Companies Similar to Finch Therapeutics
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Gatik, a new company, is creating technology for self-driving trucks that are used for short-distance…
Generalist AI develops AI and robotics technologies focused on enabling robots to perform physical tasks in…
Quintessent is a start-up in Santa Barbara that specializes in bringing quantum dot-based lasers and photonic…
Contact: Cardiosense is building a physiological waveform data platform that leverages novel multi-modal…
Thunder is a Cloud computing to democratize access to GPUs and solve the ongoing GPU shortage. Decentralized…
Deepgram helps enterprises unlock the potential of their audio data with custom trained speech recognition…
Finch Therapeutics Funding FAQs
What does Finch Therapeutics do?
Finch Therapeutics is a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs. The company uses machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus on in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models. Finch Therapeutics was founded in 2017 and is headquartered in Somerville, Massachusetts.
How much funding has Finch Therapeutics raised?
Finch Therapeutics has raised $90.0M across 1 round on record. The most recent is an undisclosed round of $90.0M announced in Sep 2020.
When did Finch Therapeutics last raise funding?
Finch Therapeutics' most recent funding round on record is an undisclosed round of $90.0M, announced in Sep 2020.
Who is the CEO of Finch Therapeutics?
Mark Smith is listed as CEO at Finch Therapeutics.
Where is Finch Therapeutics headquartered?
Finch Therapeutics is based in Somerville, Massachusetts, United States.
How many employees does Finch Therapeutics have?
Finch Therapeutics is in the 101-250 employee band.
How does Finch Therapeutics' funding compare to other Artificial Intelligence startups?
Finch Therapeutics' latest round of $90.0M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's Finch Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Finch Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.